MoDCs from PAH patients induced a stronger activation and proliferation of CD4+ T cells, which is associated with a reduced expression of IL-4 (T helper 2 response) and a higher expression of IL-17 (T helper 17 response) [97]. This evidence concerns the gene CD4 and pulmonary arterial hypertension.